Showing results (81-90 of 96) with videos related to
Sort By:
Pageof 10
The International Journal of Neuroscience|December 1, 1991
Risk factors for neuroleptic-induced movement disordersR Sandyk, S R Kay, G I Awerbuch, et al.The Journal of Nervous and Mental Disease|August 1, 1990
The Positive and Negative Syndrome Scale--Spanish adaptationS R Kay, A Fiszbein, M Vital-Herne, et al.Neuropsychobiology|January 1, 1995
Manic-depressive illness and linkage reanalysis in the Xq27-Xq28 region of chromosome XK Mendelbaum, S Sevy, D Souery, et al.Acta Psychiatrica Scandinavica|November 28, 2001
Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorderS Sevy, D G Robinson, S Holloway, et al.The American Journal of Psychiatry|July 1, 1991
Correlates of risk of suicide in violent and nonviolent psychiatric patientsA Apter, M Kotler, S Sevy, et al.The Journal of Clinical Psychiatry|June 1, 1988
Pimozide treatment of the negative schizophrenic syndrome: an open trialS S Feinberg, S R Kay, L R Elijovich, et al.The Journal of Clinical Psychiatry|July 1, 1986
Mesoridazine and thioridazine: clinical effects and blood levels in refractory schizophrenicsJ Vital-Herne, L Gerbino, S R Kay, et al.The Journal of Nervous and Mental Disease|October 1, 1990
Visual information processing in positive, mixed, and negative schizophrenic syndromesR U Weiner, L A Opler, S R Kay, et al.Schizophrenia Research|February 13, 2001
Lack of association between the T-->C 267 serotonin 5-HT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophreniaM Masellis, V S Basile, H Y Meltzer, et al.Biological Psychiatry|August 1, 1990
Neurological signs and the positive-negative dimension in schizophreniaA E Merriam, S R Kay, L A Opler, et al.Pageof 10